Literature DB >> 24582960

Pten loss induces autocrine FGF signaling to promote skin tumorigenesis.

Kristina Hertzler-Schaefer1, Grinu Mathew2, Ally-Khan Somani3, Sunil Tholpady4, Madhavi P Kadakia5, Yiping Chen6, Dan F Spandau3, Xin Zhang7.   

Abstract

Inactivation of the Pten tumor suppressor negatively regulates the PI3K-mTOR pathway. In a model of cutaneous squamous cell carcinoma (SCC), we demonstrate that deletion of Pten strongly elevates Fgf10 protein levels without increasing Fgf10 transcription in vitro and in vivo. The translational activation of Fgf10 by Pten deletion is reversed by genetic disruption of the mTORC1 complex, which also prevents skin tumorigenesis in Pten mutants. We further show that ectopic expression of Fgf10 causes skin papillomas, whereas Pten deletion-induced skin tumors are inhibited by epidermal deletion of Fgfr2. Collectively, our data identify autocrine activation of FGF signaling as an essential mechanism in promoting Pten-deficient skin tumors.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24582960      PMCID: PMC4080841          DOI: 10.1016/j.celrep.2014.01.045

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  39 in total

1.  Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye.

Authors:  R Ashery-Padan; T Marquardt; X Zhou; P Gruss
Journal:  Genes Dev       Date:  2000-11-01       Impact factor: 11.361

2.  S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway.

Authors:  Mario Pende; Sung Hee Um; Virginie Mieulet; Melanie Sticker; Valerie L Goss; Jurgen Mestan; Matthias Mueller; Stefano Fumagalli; Sara C Kozma; George Thomas
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 3.  PTEN: one gene, many syndromes.

Authors:  Charis Eng
Journal:  Hum Mutat       Date:  2003-09       Impact factor: 4.878

4.  FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinoma.

Authors:  Matthew R Ramsey; Catherine Wilson; Benjamin Ory; S Michael Rothenberg; William Faquin; Alea A Mills; Leif W Ellisen
Journal:  J Clin Invest       Date:  2013-07-08       Impact factor: 14.808

5.  Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth.

Authors:  Kai Yu; Jingsong Xu; Zhonghao Liu; Drazen Sosic; Jiansu Shao; Eric N Olson; Dwight A Towler; David M Ornitz
Journal:  Development       Date:  2003-07       Impact factor: 6.868

6.  T cell receptor delta gene mutant mice: independent generation of alpha beta T cells and programmed rearrangements of gamma delta TCR genes.

Authors:  S Itohara; P Mombaerts; J Lafaille; J Iacomini; A Nelson; A R Clarke; M L Hooper; A Farr; S Tonegawa
Journal:  Cell       Date:  1993-02-12       Impact factor: 41.582

7.  Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation.

Authors:  Akira Suzuki; Satoshi Itami; Minako Ohishi; Koichi Hamada; Tae Inoue; Nobuyasu Komazawa; Haruki Senoo; Takehiko Sasaki; Junji Takeda; Motomu Manabe; Tak Wah Mak; Toru Nakano
Journal:  Cancer Res       Date:  2003-02-01       Impact factor: 12.701

Review 8.  Pathways sufficient to induce epidermal carcinogenesis.

Authors:  Todd W Ridky; Paul A Khavari
Journal:  Cell Cycle       Date:  2004-05-15       Impact factor: 4.534

Review 9.  Fibroblast growth factors in epithelial repair and cytoprotection.

Authors:  Susanne Braun; Ulrich auf dem Keller; Heike Steiling; Sabine Werner
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-05-29       Impact factor: 6.237

10.  Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice.

Authors:  L Guo; Q C Yu; E Fuchs
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

View more
  25 in total

1.  FGF9/FGFR2 increase cell proliferation by activating ERK1/2, Rb/E2F1, and cell cycle pathways in mouse Leydig tumor cells.

Authors:  Ming-Min Chang; Meng-Shao Lai; Siou-Ying Hong; Bo-Syong Pan; Hsin Huang; Shang-Hsun Yang; Chia-Ching Wu; H Sunny Sun; Jih-Ing Chuang; Chia-Yih Wang; Bu-Miin Huang
Journal:  Cancer Sci       Date:  2018-10-23       Impact factor: 6.716

2.  Cooperative genomic alteration network reveals molecular classification across 12 major cancer types.

Authors:  Hongyi Zhang; Yulan Deng; Yong Zhang; Yanyan Ping; Hongying Zhao; Lin Pang; Xinxin Zhang; Li Wang; Chaohan Xu; Yun Xiao; Xia Li
Journal:  Nucleic Acids Res       Date:  2016-11-29       Impact factor: 16.971

3.  Genetic Mutations Underlying Phenotypic Plasticity in Basosquamous Carcinoma.

Authors:  Audris Chiang; Caroline Z Tan; François Kuonen; Luqman M Hodgkinson; Felicia Chiang; Raymond J Cho; Andrew P South; Jean Y Tang; Anne Lynn S Chang; Kerri E Rieger; Anthony E Oro; Kavita Y Sarin
Journal:  J Invest Dermatol       Date:  2019-06-15       Impact factor: 8.551

4.  Targeting of Ras-mediated FGF signaling suppresses Pten-deficient skin tumor.

Authors:  Grinu Mathew; Abdul Hannan; Kristina Hertzler-Schaefer; Fen Wang; Gen-Sheng Feng; Jian Zhong; Jean J Zhao; Julian Downward; Xin Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-31       Impact factor: 11.205

5.  Activation of S6 signaling is associated with cell survival and multinucleation in hyperplastic skin after epidermal loss of AURORA-A Kinase.

Authors:  Weston Kenneth Ryan; Josiah Fernandez; Mikayla Katherine Peterson; David William Sheneman; Brendan Keefe Podell; Subhajyoti De; Enrique Carlo Torchia
Journal:  Cell Death Differ       Date:  2018-07-26       Impact factor: 15.828

6.  Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.

Authors:  Alok R Khandelwal; Burton Kent; Savage Hillary; Md Maksudul Alam; Xiaohua Ma; Xin Gu; John DiGiovanni; Cherie-Ann O Nathan
Journal:  Mol Carcinog       Date:  2019-06-29       Impact factor: 4.784

7.  Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.

Authors:  Daniel Zingg; Jinhyuk Bhin; Julia Yemelyanenko; Sjors M Kas; Frank Rolfs; Catrin Lutz; Jessica K Lee; Sjoerd Klarenbeek; Ian M Silverman; Stefano Annunziato; Chang S Chan; Sander R Piersma; Timo Eijkman; Madelon Badoux; Ewa Gogola; Bjørn Siteur; Justin Sprengers; Bim de Klein; Richard R de Goeij-de Haas; Gregory M Riedlinger; Hua Ke; Russell Madison; Anne Paulien Drenth; Eline van der Burg; Eva Schut; Linda Henneman; Martine H van Miltenburg; Natalie Proost; Huiling Zhen; Ellen Wientjens; Roebi de Bruijn; Julian R de Ruiter; Ute Boon; Renske de Korte-Grimmerink; Bastiaan van Gerwen; Luis Féliz; Ghassan K Abou-Alfa; Jeffrey S Ross; Marieke van de Ven; Sven Rottenberg; Edwin Cuppen; Anne Vaslin Chessex; Siraj M Ali; Timothy C Burn; Connie R Jimenez; Shridar Ganesan; Lodewyk F A Wessels; Jos Jonkers
Journal:  Nature       Date:  2022-08-10       Impact factor: 69.504

8.  Lens fiber cell differentiation occurs independently of fibroblast growth factor receptor signaling in the absence of Pten.

Authors:  Stephanie L Padula; Elaine P Sidler; Brad D Wagner; Courtney J Manz; Frank J Lovicu; Michael L Robinson
Journal:  Dev Biol       Date:  2020-08-25       Impact factor: 3.582

9.  FGFR and PTEN signaling interact during lens development to regulate cell survival.

Authors:  Blake R Chaffee; Thanh V Hoang; Melissa R Leonard; Devin G Bruney; Brad D Wagner; Joseph Richard Dowd; Gustavo Leone; Michael C Ostrowski; Michael L Robinson
Journal:  Dev Biol       Date:  2016-01-05       Impact factor: 3.582

Review 10.  2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology.

Authors:  Richard J Epstein; Li Jun Tian; Yan Fei Gu
Journal:  J Oncol       Date:  2021-04-30       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.